Description  Claims  Drawing  Cited references 

WO2009105044A   [0006]  [0215] 
WO2013150303A   [0007] 
WO2014013258A   [0007] 
US5851832A   [0055] 
US6777233B   [0055] 
US6468794B   [0055] 
US5753506A   [0055] 
WO2005121318A   [0055] 
US7416888B   [0154]  [0159] 
EP1645626B1   [0156]  [0159] 
US7514259B   [0165]  [0214] 
GB2013050879W   [0181] 
WO2012004611A   [0202] 
GB1314573A   [0438] 
GB1317887A   [0438] 

PLoS One   [0003] 
Stem Cells   [0007] 
Stem Cells Dev.   [0020] 
Proteomics   [0073] 
Scientific Reports   [0073] 
Remington: The Science and Practice of Pharmacy   [0169]  [0437] 
Remington's Pharmaceutical Sciences   [0171] 
World J Gastroenterol.   [0190] 
BMC cancer   [0190] 
J. Cancer   [0190] 
ASN Neuro. 2011   [0190] 
Stem Cells Dev.   [0191] 
British Journal of Cancer   [0404] 
RNA   [0437] 
Age and Ageing   [0437] 
Cell Stem Cell   [0437] 
Cancer Lett   [0437] 
Cell Transplant   [0437] 
Arch Neurol   [0437] 
Human neural progenitor cell engraftment increases neurogenesis and microglial recruitment in the brain of rats with stroke   [0437] 
Cell Transplant.   [0437] 
Stem Cells   [0437] 
Pharmaceutics   [0437] 
Proteomics   [0437] 
Scientific Reports   [0437] 
Stroke   [0437] 
Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome   [0437] 
Nucleic Acid Research   [0437] 
Current Opinion in Molecular Therapeutics   [0437] 
Implantation of c-mycER TAM immortalized human mesencephalic-derived clonal cell lines ameliorates behavior dysfunction in a rat model of Parkinson's disease   [0437] 
Journal of Immunological Methods   [0437] 
Exp Neurol.   [0437] 
Science   [0437] 
Adv Drug Deliv Rev   [0437] 
Stem Cells   [0437] 
BMC Neuroscience   [0437] 
Neurorehabil Neural Repair   [0437] 
Nature Reviews Immunology   [0437] 
Direct Conversion of Fibroblasts into Stably Expandable Neural Stem Cells   [0437] 
Stem Cell Res   [0437] 
PLoS ONE   [0437]